Transurethral Bipolar Plasmakinetic Resection of the Prostate for the Treatment of Prostatic Hyperplas
Wang Yu-lin
Abstract
Wang Yu-lin
Abstract
Objective To evaluate the safety and efficacy of transurethral plasmakinetic resection of the prostate (TUPKRP).Methods The data of benign prostatic hyperplasia(BPH) 102 patients with TUPKRP from November 2006 to June 2008 were reviewed. The weight of the prostate was between 28 g and 160 g.Results The operation lasted for 30 ~150 min(mean,65 min).The resected tissues weighed 12~112 g.During the operation, no transurethral prostatic resection syndrome occurred.All patients were followed up for 2~12 months(mean,3months).Average maximum flow-rate(Qmax) increased from 6.2 ml/s preoperatively to 18.9 ml/s postoperatively. International prostatic symptom score(IPSS) decreased from average 26.1 preoperatively to average 7.3 postoperatively. The scores of quality of life (QOL) decreased from average 4.8 preoperatively to average 1.6 postoperatively.Conclusion TUPKRP is effective with high safety and less complications.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the safety and efficacy of transurethral plasmakinetic resection of the prostate (TUPKRP).Methods The data of benign prostatic hyperplasia(BPH) 102 patients with TUPKRP from November 2006 to June 2008 were reviewed. The weight of the prostate was between 28 g and 160 g.Results The operation lasted for 30 ~150 min(mean,65 min).The resected tissues weighed 12~112 g.During the operation, no transurethral prostatic resection syndrome occurred.All patients were followed up for 2~12 months(mean,3months).Average maximum flow-rate(Qmax) increased from 6.2 ml/s preoperatively to 18.9 ml/s postoperatively. International prostatic symptom score(IPSS) decreased from average 26.1 preoperatively to average 7.3 postoperatively. The scores of quality of life (QOL) decreased from average 4.8 preoperatively to average 1.6 postoperatively.Conclusion TUPKRP is effective with high safety and less complications.
Key concepts: Medicine, Hyperplasia, Prostate, Urology, Quality of life (healthcare), Resection, International Prostate Symptom Score, Transurethral resection of the prostate